Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
   31  Vitamins
   32  Nutrients, tonics
   33  Blood and body fluid agents
   34  Dialysis agents
   39  Other agents affecting metabolism
     391  Liver disease agents
     392  Antidotes
     393  Habitual intoxication agents
     394  Gout preparations
     395  Enzyme preparations
     396  Antidiabetic agents
     397  Metabolic disease preparations & combinations
     399  Miscellaneous
       3991  Chondroitins
       3992  Adenosines
       3993  Prolactins
       3999  Others
         D02397  Arginine glutamate (USAN)
         D00352  Lactulose (JP16/USP/INN)
         D02039  Lactitol hydrate (JAN)
         D02030  Levocarnitine chloride (JAN)
         D02176  Levocarnitine (JAN/USP/INN)
         D07523  Betaine (JAN)
         D00086  Thioctic acid (JAN)
         D05032  Miglustat (JAN/USAN/INN)
         D01798  Sapropterin hydrochloride (JAN); Sapropterin dihydrochloride (USAN)
         D01766  Camostat mesilate (JP16)
         D08990  Romiplostim (genetical recombination) (JAN); Romiplostim (USAN/INN)
         D03978  Eltrombopag olamine (JAN/USAN)
         D03231  Epoetin alfa (genetical recombination) (JP16); Epoetin alfa (USAN/INN)
         D03232  Epoetin beta (genetical recombination) (JP16); Epoetin beta (USAN/INN)
         D09737  Epoetin kappa (genetical recombination) (Epoetin alfa biosimilar 1) (JAN); Epoetin kappa (INN)
         D09998  Epoetin beta pegol (genetical recombination) (JAN)
         D03651  Darbepoetin alfa (genetical recombination) (JAN); Darbepoetin alfa (USAN/INN)
         D01126  L-Arginine hydrochloride (JP16); Arginine hydrochloride (USP)
         D00294  Diazoxide (JAN/USP/INN)
         D03354  Purified sodium hyaluronate (JP16); Sodium hyaluronate (JAN); Hyaluronate sodium (USAN)
         D01995  Inosine pranobex (JAN)
         D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
         D02217  Raloxifene hydrochloride (JAN/USP)
         D03062  Bazedoxifene acetate (JAN/USAN)
         D00249  Calcitonin salmon (JP16/USAN/INN)
         D03287  Elcatonin (JP16/INN)
         D03505  Cinacalcet hydrochloride (JAN/USAN)
         D00142  Methotrexate (JP16/USP/INN)
         D02714  Everolimus (JAN/USAN/INN)
         D00752  Mycophenolate mofetil (JAN/USAN)
         D00749  Leflunomide (JAN/USAN/INN)
         D01566  Gusperimus hydrochloride (JAN); Gusperimus trihydrochloride (USAN)
         D03203  Abatacept (genetical recombination) (JAN); Abatacept (USAN/INN)
         D04187  Fingolimod hydrochloride (JAN/USAN)
         D09783  Tofacitinib citrate (JAN/USAN)
         D00742  Etanercept (genetical recombination) (JAN); Etanercept (USAN/INN)
         D02597  Adalimumab (genetical recombination) (JAN); Adalimumab (USAN/INN)
         D03441  Certolizumab pegol (genetical recombination) (JAN); Certolizumab pegol (USAN/INN)
         D04358  Golimumab (genetical recombination) (JAN); Golimumab (USAN/INN)
         D09214  Ustekinumab (genetical recombination) (JAN); Ustekinumab (USAN/INN)
         D09315  Canakinumab (genetical recombination) (JAN); Canakinumab (USAN/INN)
         D00184  Ciclosporin (JP16); Cyclosporine (USP)
         D00238  Azathioprine (JP16/USP/INN)
         D01583  Pirfenidone (JAN/USAN/INN)
         D00314  Etidronate disodium (JP16/USP)
         D00941  Pamidronate disodium hydrate (JAN); Pamidronate disodium (USAN)
         D00939  Alendronate sodium hydrate (JP16); Alendronate sodium (USAN)
         D04486  Ibandronate sodium hydrate (JAN); Ibandronate sodium (USAN)
         D03234  Sodium risedronate hydrate (JP16)
         D01968  Zoledronic acid hydrate (JAN); Zoledronic acid (USAN)
         D01338  Ipriflavone (JP16/INN)
         D03684  Denosumab (genetical recombination) (JAN); Denosumab (USAN)
         D00026  L-Cysteine (JP16)
         D01146  Iguratimod (JAN/INN)
         D01392  Mizoribine (JP16/INN)
         D01670  Nafamostat mesilate (JP16); Nafamostat mesylate (USAN)
         D01672  Gabexate mesilate (JP16)
         D01684  Ozagrel sodium (JP16)
         D01688  Epalrestat (JP16/INN)
         D01918  Sivelestat sodium hydrate (JP16); Sivelestat sodium (USAN); Sivelestat sodium for injection (JP16)
         D02280  Sodium L-glutamate hydrate (JAN); Monosodium glutamate (NF)
         D04285  Concentrated glycerin - fructose mixt
         D05183  Ulinastatin (JP16)
         D08754  L-Arginine - L-arginine hydrochloride mixt
         D09198  Minodronic acid hydrate (JAN)
A05BA01
A06AD11
A06AD12
A16AA01
A16AA01
A16AA06
A16AX01
A16AX06
A16AX07
B02AB04
B02BX04
B02BX05
B03XA01
B03XA01
B03XA01
B03XA01
B03XA02
B05XB01
C02DA01 V03AH01
D03AX05 M09AX01 R01AX09 S01KA01
D06BB05 G01AX02 J05AX05 S01XA10
D11AH01 L04AD02
G03XC01
G03XC02
H05BA01
H05BA04
H05BX01
L01BA01 L04AX03
L01XE10 L04AA18
L04AA06
L04AA13
L04AA19
L04AA24
L04AA27
L04AA29
L04AB01
L04AB04
L04AB05
L04AB06
L04AC05
L04AC08
L04AD01 S01XA18
L04AX01
L04AX05
M05BA01
M05BA03
M05BA04
M05BA06
M05BA07
M05BA08
M05BX01
M05BX04
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 26, 2014
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version